Henry spent four years at university studying biochemistry before realising that the laboratory life wasn’t for him, and going to work for a science journal instead. From there, he went on to do a Masters in Science Communication and, after a brief flirtation with science journalism, in 2003 he started working for Cancer Research UK.
All the events from the third day of this year’s National Cancer Research Institute conference in Liverpool
We look back to the 1990s, and to our ‘first-in-man’ trial of prostate cancer drug abiraterone – a vital step in the drug’s development
We quiz our chief clinician, Professor Peter Johnson, to get his take on the history of cancer immunotherapy and where the field is heading.
We look at welcome new stats published today, show that the number of cancer patients diagnosed in an emergency is falling.
Two years ago we launched a pioneering £15m lung cancer study. Find out what’s happened since, through the eyes of Terrence, a patient taking part.
Our regular round-up of the week’s cancer news.
All the week’s news, digested for you.
Our new , rapid turn-around funding scheme aims to fund high-risk research that we wouldn’t normally fund
A new research centre, ‘organoids’ to beat cancer, and the deadly effects of smoking… all this and more in our weekly news digest.
We caught up with Professor Nic Jones, director of the new Manchester Cancer Research Centre, to hear why he’s so excited about the new building